Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenny Roose

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Advanced Healthcare Materials|April 25, 2017
Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the PeptideVimal K Udhayakumar, Ans De Beuckelaer, Joanne McCaffrey, et al.
Journal of Virology|September 2, 2016
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceArwen F Altenburg, Carolien E van de Sandt, Stella E van Trierum, et al.
Nature Communications|June 7, 2020
Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Ebiomedicine|January 17, 2024
Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warrantedDelphine Diana Acar, Wojciech Witkowski, Magdalena Wejda, et al.
Nature Communications|November 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamstersRobbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Advanced Healthcare Materials|April 25, 2017
Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the PeptideVimal K Udhayakumar, Ans De Beuckelaer, Joanne McCaffrey, et al.
Journal of Virology|September 2, 2016
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceArwen F Altenburg, Carolien E van de Sandt, Stella E van Trierum, et al.
Nature Communications|June 7, 2020
Reverse engineering synthetic antiviral amyloidsEmiel Michiels, Kenny Roose, Rodrigo Gallardo, et al.
Ebiomedicine|January 17, 2024
Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warrantedDelphine Diana Acar, Wojciech Witkowski, Magdalena Wejda, et al.
Nature Communications|November 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamstersRobbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein, et al.
Science Translational Medicine|October 5, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal modelsBert Schepens, Loes van Schie, Wim Nerinckx, et al.
Pageof 4